Rock Creek Pharmaceuticals, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1985-06-01
- Employees
- 11
- Market Cap
- -
- Website
- http://starscientific.com
Clinical Trials
6
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Safety, Tolerability, and Pharmacokinetics of Modified and Immediate Release Anatabine Citrate Formulations
- Conditions
- Pharmacokinetics of Anatabine
- Interventions
- Drug: Modified Release Formulation x (MRx)
- First Posted Date
- 2015-05-04
- Last Posted Date
- 2015-11-01
- Lead Sponsor
- Rock Creek Pharmaceuticals, Inc.
- Target Recruit Count
- 37
- Registration Number
- NCT02432313
- Locations
- 🇬🇧
Quotient Clinical, Nottingham, United Kingdom
A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea
- Conditions
- Rosacea
- First Posted Date
- 2012-12-04
- Last Posted Date
- 2015-11-01
- Lead Sponsor
- Rock Creek Pharmaceuticals, Inc.
- Target Recruit Count
- 117
- Registration Number
- NCT01740934
- Locations
- 🇺🇸
Susan H. Weinkle, MD, Bradenton, Florida, United States
🇺🇸Lupo Center for Aesthetic & General Dermatology, New Orleans, Louisiana, United States
🇺🇸Diane Berson, MD, New York, New York, United States
Study to Evaluate Dietary Supplementation With a Version of Anatabloc(R) in Subjects With Alzheimer's Disease
- Conditions
- Alzheimer Disease
- First Posted Date
- 2012-08-21
- Last Posted Date
- 2015-04-30
- Lead Sponsor
- Rock Creek Pharmaceuticals, Inc.
- Target Recruit Count
- 85
- Registration Number
- NCT01669876
- Locations
- 🇺🇸
Roskamp Institute, Sarasota, Florida, United States
Evaluating the Dietary Supplement Anatabloc in Thyroid Health-ASAP (Antabloc Supplementation Autoimmune Prevention)
- Conditions
- Thyroiditis, Autoimmune
- First Posted Date
- 2012-03-12
- Last Posted Date
- 2015-11-01
- Lead Sponsor
- Rock Creek Pharmaceuticals, Inc.
- Target Recruit Count
- 165
- Registration Number
- NCT01551498
- Locations
- 🇺🇸
Metabolic Research Institute, Inc., West Palm Beach, Florida, United States
🇺🇸Florida Medical Clinic, P.A., Zephyrhills, Florida, United States
🇺🇸Robert J. Becker, M.D., LTD, La Grange, Illinois, United States
Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke
- Conditions
- Tobacco Use DisorderTobacco DependenceSmoking
- First Posted Date
- 2011-09-02
- Last Posted Date
- 2015-10-30
- Lead Sponsor
- Rock Creek Pharmaceuticals, Inc.
- Target Recruit Count
- 109
- Registration Number
- NCT01428310
- Locations
- 🇺🇸
Comfort Inn, Martinsburg, West Virginia, United States
- Prev
- 1
- 2
- Next